152 related articles for article (PubMed ID: 27062033)
1. Aberrant Expression of Calretinin, D2-40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis.
Foda AA; El-Hawary AK; Hamed H
Pathol Oncol Res; 2016 Oct; 22(4):725-32. PubMed ID: 27062033
[TBL] [Abstract][Full Text] [Related]
2. Relation of glypican-3 and E-cadherin expressions to clinicopathological features and prognosis of mucinous and non-mucinous colorectal adenocarcinoma.
Foda AA; Mohammad MA; Abdel-Aziz A; El-Hawary AK
Tumour Biol; 2015 Jun; 36(6):4671-9. PubMed ID: 25619476
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expressions of c-KIT and DOG-1 in mucinous and nonmucinous colorectal carcinomas and relation to clinicopathologic features and prognosis.
Foda AA; Mohamed MA
Ann Diagn Pathol; 2015 Oct; 19(5):335-40. PubMed ID: 26272691
[TBL] [Abstract][Full Text] [Related]
4. Role of ERCC1 expression in colorectal adenoma-carcinoma sequence and relation to other mismatch repair proteins expression, clinicopathological features and prognosis in mucinous and non-mucinous colorectal carcinoma.
Foda AA; Palicelli A; Shebl A; Boldorini R; Elnaghi K; ElHawary AK
Indian J Pathol Microbiol; 2019; 62(3):405-412. PubMed ID: 31361228
[TBL] [Abstract][Full Text] [Related]
5. Mucinous Colorectal Adenocarcinoma: Influence of EGFR and E-Cadherin Expression on Clinicopathologic Features and Prognosis.
Foda AA; AbdelAziz A; El-Hawary AK; Hosni A; Zalata KR; Gado AI
Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):506-15. PubMed ID: 26262813
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of matrix metalloproteinase-13 in mucinous and nonmucinous colorectal carcinomas.
Foda AA; El-Hawary AK; Abdel-Aziz A
Ann Diagn Pathol; 2013 Aug; 17(4):347-51. PubMed ID: 23665089
[TBL] [Abstract][Full Text] [Related]
7. Colorectal adenocarcinoma with mucinous component: relation of MMP-13, EGFR, and E-cadherin expressions to clinicopathological features and prognosis.
Foda AA; El-Hawary AK; Aziz AA
APMIS; 2015 Jun; 123(6):502-8. PubMed ID: 25907382
[TBL] [Abstract][Full Text] [Related]
8. Use of mesothelin as a marker for mesothelial cells in cytologic specimens.
Kachali C; Eltoum I; Horton D; Chhieng DC
Semin Diagn Pathol; 2006 Feb; 23(1):20-4. PubMed ID: 17044192
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.
de Cuba EM; de Hingh IH; Sluiter NR; Kwakman R; Coupé VM; Beliën JA; Verwaal VJ; Meijerink WJ; Delis-van Diemen PM; Bonjer HJ; Meijer GA; Te Velde EA
Ann Surg Oncol; 2016 May; 23(5):1601-8. PubMed ID: 26727921
[TBL] [Abstract][Full Text] [Related]
10. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
Tabrizi AD; Kalloger SE; Köbel M; Cipollone J; Roskelley CD; Mehl E; Gilks CB
Int J Gynecol Pathol; 2010 Mar; 29(2):99-107. PubMed ID: 20173494
[TBL] [Abstract][Full Text] [Related]
11. C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.
Kawamata F; Homma S; Kamachi H; Einama T; Kato Y; Tsuda M; Tanaka S; Maeda M; Kajino K; Hino O; Takahashi N; Kamiyama T; Nishihara H; Taketomi A; Todo S
J Gastroenterol; 2014 Jan; 49(1):81-92. PubMed ID: 23512344
[TBL] [Abstract][Full Text] [Related]
12. Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes.
Han SH; Joo M; Kim H; Chang S
J Pathol Transl Med; 2017 Mar; 51(2):122-128. PubMed ID: 28196410
[TBL] [Abstract][Full Text] [Related]
13. Mesothelin expression and its prognostic role according to microsatellite instability status in colorectal adenocarcinoma.
Kim H; Chung Y; Paik SS; Jang K; Shin SJ
Medicine (Baltimore); 2019 Jun; 98(26):e16207. PubMed ID: 31261569
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of mesothelin expression in colorectal cancer disclosed by area-specific four-point tissue microarrays.
Shiraishi T; Shinto E; Nearchou IP; Tsuda H; Kajiwara Y; Einama T; Caie PD; Kishi Y; Ueno H
Virchows Arch; 2020 Sep; 477(3):409-420. PubMed ID: 32107600
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of mucinous components correlated with microsatellite instability in patients with colorectal cancer.
Yoon YS; Kim J; Hong SM; Lee JL; Kim CW; Park IJ; Lim SB; Yu CS; Kim JC
Colorectal Dis; 2015 Aug; 17(8):O161-7. PubMed ID: 26095997
[TBL] [Abstract][Full Text] [Related]
16. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary.
Cao D; Ji H; Ronnett BM
Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of E-cadherin and Cox 2 expression in Tunisian patients with colorectal mucinous adenocarcinoma.
Triki M; Kallel R; Feki J; Mellouli M; Charfi S; Ayadi L; Boudawara T
Ann Diagn Pathol; 2020 Dec; 49():151624. PubMed ID: 32919337
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of mesothelin expression in peritoneal disease from colorectal and appendiceal cancers.
Yoon DH; Ibrahim A; Tatishchev S; Duldulao MPN; Lee SW; Shin J
J Surg Oncol; 2021 Dec; 124(7):1091-1097. PubMed ID: 34310720
[TBL] [Abstract][Full Text] [Related]
19. Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses.
Kim YH; Min BH; Kim SJ; Choi HK; Kim KM; Chun HK; Lee H; Kim JY; Chang DK; Son HJ; Rhee PL; Rhee JC; Kim JJ
Ann Surg Oncol; 2010 May; 17(5):1435-41. PubMed ID: 20049642
[TBL] [Abstract][Full Text] [Related]
20. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects.
Debunne H; Ceelen W
Acta Chir Belg; 2013; 113(6):385-90. PubMed ID: 24494463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
